People: Optimer Pharmaceuticals Inc (OPTR.O)

Mr. Stephen W. Webster has been appointed as Chief Financial Officer and Principal Financial and Accounting Officer of Optimer Pharmaceuticals, Inc., effective June 25, 2012. Prior to joining Optimer, he served as the Chief Financial Officer of Adolor Corporation from June 2008 until its acquisition by Cubist Pharmaceuticals, Inc. in December 2011. From 2007 until joining Adolor Corporation in 2008, Mr. Webster served as Managing Director, Investment Banking Division, Health Care Group for Broadpoint Capital (formerly First Albany Capital). Mr. Webster previously served as co-founder, President and Chief Executive Officer for Neuronyx, Inc. From 1987 to 2000, Mr. Webster served in positions of increased responsibility, including as Director, Investment Banking Division, Health Care Group for PaineWebber Incorporated. Mr. Webster holds an A.B. in Economics cum laude from Dartmouth College and a Master of Business Administration in Finance from The Wharton School, The University of Pennsylvania.